OUR PRODUCTS

MOBILE APPS

GENERAL INFO

RNXT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

RenovoRx (RNXT) Earnings Date & Reports

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RNXT is expected to report earnings to -7 cents per share on November 17

Q3'25

Est.

$-0.08

Q2'25

Beat

by $0.01

Q1'25

Beat

by $0.01

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.02

The last earnings report on August 14 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 81.23K shares outstanding, the current market capitalization sits at 34.94M.

View a ticker or compare two or three

Compare

RNXT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RNXT
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RNXT showed earnings on August 14, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

4546 El Camino Real

Phone

+1 650 284-4433

Employees

Web

https://www.renovorx.com